Leukotriene-deficient mice generated by targeted disruption of the 5-lipoxygenase gene.
Funk
C D
CD
Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Chen
X S
XS
Kurre
U
U
Griffis
G
G
D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics*; D016718:Arachidonic Acid / Q000494:pharmacology; D001854:Bone Marrow Cells; D002351:Carrageenan; D015232:Dinoprostone / Q000032:analysis; D005260:Female; D007249:Inflammation / Q000503:physiopathology; D017997:Leukotriene C4 / Q000032:analysis; D015289:Leukotrienes / Q000172:deficiency*; D008264:Macrophages / Q000502:physiology; D008297:Male; D008407:Mast Cells / Q000166:cytology / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D008817:Mice, Mutant Strains; D010587:Phagocytosis; D010641:Phenotype; D010972:Platelet Activating Factor / Q000494:pharmacology; D013154:Spleen / Q000502:physiology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D015289:Leukotrienes; D010972:Platelet Activating Factor; D016718:Arachidonic Acid; D017997:Leukotriene C4; D002351:Carrageenan; D001094:Arachidonate 5-Lipoxygenase; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate